BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2035890)

  • 1. ACE inhibitors in the elderly.
    Posvar EL; Sedman AJ
    Angiology; 1991 May; 42(5):387-96. PubMed ID: 2035890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetics of captopril, enalapril, and quinapril.
    Vertes V; Haynie R
    Am J Cardiol; 1992 Apr; 69(10):8C-16C. PubMed ID: 1546641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and efficacy of quinapril in the treatment of mild to moderate essential hypertension.
    Frishman WH
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII19-25. PubMed ID: 2189617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of moderate to severe hypertension with ACE inhibitors.
    Goldstein RJ
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S29-35. PubMed ID: 1691404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of quinapril in the treatment of moderate to severe and severe hypertension: comparison to captopril.
    Frishman WH
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII26-31. PubMed ID: 2189618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting enzyme inhibitors and the otolaryngologist.
    Cruickshank HE
    Clin Otolaryngol Allied Sci; 1995 Jun; 20(3):189-91. PubMed ID: 7554324
    [No Abstract]   [Full Text] [Related]  

  • 7. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
    Plosker GL; Sorkin EM
    Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the efficacy and safety of quinapril with that of enalapril in the treatment of mild to moderate essential hypertension.
    Taylor SH
    Angiology; 1989 Apr; 40(4 Pt 2):382-8. PubMed ID: 2539763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinapril: a new second-generation ACE inhibitor.
    Cetnarowski-Cropp AB
    DICP; 1991 May; 25(5):499-504. PubMed ID: 2068835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of quinapril, a new ACE inhibitor.
    Frank GJ; Knapp LE; Olson SC; Phelps MC; Quade MM; Rieger MM; Sedman AJ
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S14-23. PubMed ID: 1691402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of mild to moderate hypertension with ACE inhibitors.
    Taylor SH
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S24-8. PubMed ID: 1691403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety profile of quinapril: is there a difference among ACE inhibitors?
    Canter D; Frank GJ; Knapp LE; McLain RW
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII39-42. PubMed ID: 2189620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?
    Francis GS; Gassler JP
    Cleve Clin J Med; 2001 Mar; 68(3):185-6. PubMed ID: 11263844
    [No Abstract]   [Full Text] [Related]  

  • 14. Does the duration of action of angiotensin converting enzyme inhibitors affect their safety and adverse effects?
    Frank GJ
    J Hypertens Suppl; 1989 Sep; 7(5):S17-22. PubMed ID: 2553900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
    Puig JG; Mateos FA; Ramos TH; Lavilla MP; Capitán MC; Gil A
    Am J Hypertens; 1994 Jan; 7(1):46-51. PubMed ID: 8136110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy and safety of quinapril vs. captopril in treatment of moderate to severe hypertension.
    Schnaper HW
    Angiology; 1989 Apr; 40(4 Pt 2):389-95. PubMed ID: 2650582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE inhibitors in the treatment of hypertension in the older patient.
    Canter D; Frank G
    Eur Heart J; 1990 May; 11 Suppl D():33-43. PubMed ID: 2193809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety and tolerability of quinapril.
    Knapp LE; Frank GJ; McLain R; Rieger MM; Posvar E; Singer R
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S47-55. PubMed ID: 1691407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
    Kontopoulos AG; Athyros VG; Papageorgiou AA; Skeberis VM; Basayiannis EC; Boudoulas H
    Coron Artery Dis; 1997; 8(8-9):517-24. PubMed ID: 9431480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of heart failure in dogs with ACe inhibitors: comparison of quinapril and captopril].
    Morisse B; Kersten U
    Tierarztl Prax; 1995 Oct; 23(5):489-96. PubMed ID: 8585063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.